Articles Vol. 67 No. CĐ3-NCKH 02/04/2026

SURVEY ON DRUG-RELATED PROBLEMS IN OUTPATIENTS WITH HEART FAILURE AT NGUYEN TRI PHUONG HOSPITAL

Luu Thuy Le Mai1,2, Pham Thi Ngoc Bich1,2, Nguyen Lien Nhut1,2, Cao Phuong Duy3,4, Vo Thi Ha1,2,3,4
1 Pham Ngoc Thach University of Medicine
2 Trường Đại học Y khoa Phạm Ngọc Thạch
3 Nguyen Tri Phuong Hospital
4 Bệnh viện Nguyễn Tri Phương
DOI: 10.52163/yhc.v67iCD3.4736
33 Views
0 Downloads
Keywords
drug-related issues, pharmaceutical interventions, outpatients, heart failure
Abstract

Objective: To survey drug-related problems (DRPs) and associated factors in outpatients with heart failure at Nguyen Tri Phuong Hospital.

Subject and Method: A cross-sectional, retrospective study was conducted on 120 outpatients with chronic heart failure from January 2022 to April 2023. DRPs were identified by clinical pharmacists using the Vimed tool and were re-evaluated by a cardiologist.

Results: 90.0% of patients used at least five types of medications. A total of 292 DRPs were detected in 106 patients (88.3%), with an average of 2.4 ± 1.56 DRPs per patient. The most common DRPs included inappropriate drug use (36.3%), drug interactions (33.6%), lack of treatment monitoring (13.0%), and under-prescription (9.9%). Univariate and multivariate analyses showed that co-existing ischemic heart disease, atrial fibrillation and the use of more than 5 medications were associated with the occurrence of DRPs. A total of 269 pharmacist interventions were proposed, with 66.9% receiving physician approval.

Conclusion: The study demonstrated the role of clinical pharmacists in detecting DRPs and proposing pharmacist interventions for outpatients with heart failure.

References
[1]
Bộ Y tế. Hướng dẫn thực hành dược lâm sàng cho dược sĩ trong một số bệnh không lây nhiễm. Hà Nội: Bộ Y tế; 2019. Google Scholar
[2]
Amankwa HM, Agyei BG, Ameyaw E, et al. Drug-related problems among hospitalized hypertensive and heart failure patients and physician acceptance of pharmacists' interventions at a teaching hospital in Ghana. Health Sci Rep. 2022;5(5):e786. Google Scholar
[3]
Hsu WT, Chou CY, Chang HC, et al. Drug-related problems vary with medication category and treatment duration in Taiwanese heart failure outpatients receiving case management. J Formos Med Assoc. 2016;115(5):335–342. Google Scholar
[4]
Tsige AW, Melaku T, Amare F, et al. Drug-related problems among ambulatory heart failure patients on follow-up at Debre Berhan Comprehensive Specialized Hospital, Ethiopia. Ther Clin Risk Manag. 2021;17:1165–1175. Google Scholar
[5]
Sefera B, Wubishet BL, Abebe S, et al. Drug-related problems and its predictors among hospitalized heart failure patients at Jimma Medical Center, South West Ethiopia: a prospective interventional study. BMC Cardiovasc Disord. 2022;22(1):418. Google Scholar
[6]
Vo TH, Nguyen AT, Pham TT, et al. Development and validation of the Vi-Med® tool for medication review. J Appl Pharm Sci. 2020;10(2):86–96. Google Scholar
[7]
Bộ Y tế. Hướng dẫn chẩn đoán và điều trị suy tim cấp và mạn. Hà Nội: Bộ Y tế; 2022. Google Scholar
[8]
Hội Tim mạch học Việt Nam. Khuyến cáo của Hội Tim mạch Quốc gia về chẩn đoán và điều trị suy tim cấp và suy tim mạn. Hà Nội: Hội Tim mạch học Việt Nam; 2022. Google Scholar